Gemcitabine in combination with cisplatin (GP) versus gemcitabine (G) alone in the treatment of locally advanced or metastatic pancreatic cancer: Final results of a multicenter randomized phase II study.

被引：0
|
作者：
Viret, F
Ychou, M
Lepille, D
Mineur, L
Navarro, F
Topart, D
Fonck, M
Goineau, J
Madroszyk-Flandin, A
Chouaki, N
机构：
[1] Inst J Paoli I Calmettes, F-13009 Marseille, France
[2] Ctr Val Aurelle, Montpellier, France
[3] Clin Pasteur, Evreux, France
[4] Clin St Catherine, Avignon, France
[5] Hop Caremeau, Nimes, France
[6] Inst Bergonie, Bordeaux, France
[7] Hop Louis Pasteur, Colmar, France
[8] CHU Jean Minjoz, Besancon, France
[9] Lilly, Suresnes, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4118
引用
收藏
页码：342S / 342S
页数：1
相关论文
共 50 条
  • [31] A phase II trial of Erlotinib in combination with gemcitabine and cisplatin in advanced pancreatic cancer
    In Gyu Hwang
    Joung-Soon Jang
    Sung Yong Oh
    Suee Lee
    Hyuk Chan Kwon
    Gyeong Won Lee
    Seil Go
    Myoung Hee Kang
    Young Joo Cha
    Jung Hun Kang
    Investigational New Drugs, 2012, 30 : 2371 - 2376
  • [32] A multicenter randomized phase II study of NPC-1C (N) in combination with gemcitabine (G) and nab-paclitaxel (A) versus G and A alone in patients with metastatic or locally advanced pancreatic cancer (PC) previously treated with folfirinox (F)
    Duffy, Austin G.
    Beg, Muhammad Shaalan
    Greten, Tim F.
    Beatson, Melony A.
    Mavroukakis, Sharon
    Patel, Sandip Pravin
    Morse, Michael A.
    Arlen, Philip M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [33] Final results of randomized study of gemcitabine (G) plus cisplatin (P) versus etoposide (E) plus cisplatin in locally advanced or metastatic non small cell lung cancer (NSCLC)
    Bousahba, A., Sr.
    Bereksi-Reguig, F.
    Seghier, F.
    Boukerche, A.
    Dali-Youcef, A.
    Djellali, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer.
    Lim, Sung Hee
    Yun, Jina
    Lee, Min-Young
    Kim, Han Jo
    Kim, Kyoung Ha
    Kim, Se Hyung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Hong, Dae Sik
    Choi, Hyun Jong
    Moon, Jong Ho
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [35] Phase II study of Gemcitabine and Curcumin (Meriva®) as first line treatment for locally advanced or metastatic pancreatic cancer: preliminary results
    Solda, C.
    Bardini, R.
    Sperti, C.
    Da Dalt, G.
    Gion, M.
    Fiduccia, P.
    Ursini, F.
    Aliberti, C.
    Pastorelli, D.
    ANNALS OF ONCOLOGY, 2015, 26 : 102 - 102
  • [36] Gemcitabine and cisplatin versus methotrexate vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multinational, multicenter, phase III study
    von der Maase, H
    Hansen, SW
    Roberts, JT
    Dogliotti, L
    Oliver, T
    Moore, MJ
    Bodrogi, I
    Albers, P
    Knuth, A
    Lippert, CM
    Kerbrat, P
    Rovira, PS
    Wersall, P
    Cleall, SP
    Roychowdhury, DF
    Tomlin, I
    Visseren-Grul, CM
    Conte, PF
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (17) : 3068 - 3077
  • [37] Randomized controlled trial of gemcitabine in combination with UFT versus gemcitabine alone in patients with advanced pancreatic cancer.
    Ohkawa, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 346S - 346S
  • [38] Meta-analysis of gemcitabine and cisplatin combination chemotherapy versus gemcitabine alone for pancreatic cancer
    Huang, Diyu
    Fang, Jie
    Luo, Gaojian
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (05) : 104 - 108
  • [39] A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer
    Basil F. El-Rayes
    Mark M. Zalupski
    Anthony F. Shields
    Ann Marie Ferris
    Ulka Vaishampayan
    Lance K. Heilbrun
    Raghu Venkatramanamoorthy
    Volkan Adsay
    Philip A. Philip
    Investigational New Drugs, 2005, 23 : 583 - 590
  • [40] Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia
    Li, Yanxun
    Sun, Jinjin
    Jiang, Zhijia
    Zhang, Linqiang
    Liu, Geng
    JOURNAL OF CHEMOTHERAPY, 2015, 27 (04) : 227 - 234
12345